Discover more near‑term opportunities with better event intelligence.
Fundz combines its own real-time funding and M&A intelligence with executive moves, hiring shifts and other company changes, weighs each signal against your ideal customer profile, and delivers a ranked daily shortlist with the context and decision maker to contact. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Pharming Appoints Leverne Marsh and Kenneth Lynard as Interim Co-CEOs
Pharming has appointed Leverne Marsh and Kenneth Lynard as Interim Co-CEOs following the departure of Fabrice Chouraqui as CEO. This change aims to ensure continuity of leadership as the company searches for a permanent successor.
Company Information
Company
Pharming Group
Location
Leiden, South Holland, Netherlands
About
Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.
Fundz sees it the moment Pharming Group changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
LeidenBiotechnologyHealth CareTherapeuticsPharmaceutical